Intermediates & Advanced Intermediates
A broad portfolio of pharmaceutical intermediates and advanced intermediates supporting the synthesis of innovator and generic APIs, backed by robust process chemistry and analytical control.
Building blocks for complex molecules
Consistent Quality, Comprehensive Regulatory Documentation
A broad portfolio of pharmaceutical intermediates and advanced intermediates supporting the synthesis of innovator and generic APIs, backed by robust process chemistry and analytical control.
- Broad range of pharmaceutical and advanced intermediates for generic and innovator APIs.
- Robust, scalable process chemistry backed by structural characterization.
- Custom synthesis and contract manufacturing available on request.
Intermediates Product List
Search our chemical portfolio below. Click Enquire on any product to request specifications, analytical samples or regulatory documentation.
Showing 56 of 56 products
| # | Product | CAS No. | Enquiry |
|---|---|---|---|
| 1 | 2-Butyl-3-(4-hydroxy-3,5-diiodobenzoyl)benzofuran | 1951-26-4 | |
| 2 | 1-Phenylpiperidin-2-one | 4780-09-7 | |
| 3 | Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate hydrobromide | 70381-75-8 | |
| 4 | 1-(4-Nitrophenyl)piperidin-2-one | 38560-30-4 | |
| 5 | 3,3-Dichloro-1-(4-nitrophenyl)piperidin-2-one | 881386-01-2 | |
| 6 | 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 503615-03-0 | |
| 7 | 1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one | 1267610-26-3 | |
| 8 | 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one | 545445-44-1 | |
| 9 | Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate | 27143-07-3 | |
| 10 | Ethyl 1-(4-methoxyphenyl)-4-oxo-5-(4-(2-oxopiperidin-1-yl)phenyl)-tetrahydropyrazolopyridine-3-carboxylate | 503614-91-3 | |
| 11 | 1-(4-Methoxyphenyl)-4-oxo-5-(4-(2-oxopiperidin-1-yl)phenyl)-tetrahydropyrazolopyridine-3-carboxylic acid | 503614-92-4 | |
| 12 | (S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-aminium acetyl-L-leucinate | 608141-43-1 | |
| 13 | 1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethan-1-amine | 253168-94-4 | |
| 14 | N-(1,3-Dioxo-1,3-dihydroisobenzofuran-4-yl)acetamide | 6296-53-3 | |
| 15 | 2-(Benzhydrylsulfinyl)acetic acid | 63547-24-0 | |
| 16 | Methyl 2-(benzhydrylsulfinyl)acetate | 63547-25-1 | |
| 17 | Ethyl 2-(benzhydrylsulfinyl)acetate | 118286-19-4 | |
| 18 | (R)-2-(Benzhydrylsulfinyl)acetic acid | 112111-45-2 | |
| 19 | (R)-Methyl 2-(benzhydrylsulfinyl)acetate | 713134-72-6 | |
| 20 | (R)-Ethyl 2-(benzhydrylsulfinyl)acetate | 827604-05-7 | |
| 21 | 2-Oxo-3-((2'-5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-benzimidazole-4-carboxylic acid | 1442400-68-1 | |
| 22 | Methyl 2-ethoxy-1-((2'-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-benzimidazole-7-carboxylate | 147403-52-9 | |
| 23 | 1-(Propan-2-ylamino)-3-[4-(2-propan-2-yloxyethoxymethyl)phenoxy]propan-2-ol | 66722-44-9 | |
| 24 | Dabigatran etexilate mesylate intermediate (β-alanine ethyl ester) | 211915-06-9 | |
| 25 | Ethyl 3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-benzimidazole-5-carboxamido)propanoate HCl | 211914-50-0 | |
| 26 | 3-(2-(((4-Carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-benzimidazole-5-carboxamido)propanoic acid | 211914-51-1 | |
| 27 | Ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-benzimidazole-5-carboxamido)propanoate | 211915-84-3 | |
| 28 | (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydropyran-3,4,5-triyl triacetate | 461432-25-7 | |
| 29 | 2-(2-Hydroxyphenyl)-4H-benzo[e][1,3]oxazin-4-one | 1218-69-5 | |
| 30 | 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-benzimidazole | 103577-40-8 | |
| 31 | 5,6-Dimethoxy-2-(pyridin-4-ylmethylene)-2,3-dihydro-1H-inden-1-one | 4803-74-1 | |
| 32 | 5,6-Dimethoxy-2-(piperidin-4-ylmethyl)-2,3-dihydro-1H-inden-1-one | 120013-39-0 | |
| 33 | tert-Butyl ((1R,2S,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate | 480452-36-6 | |
| 34 | (2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one | 42399-49-5 | |
| 35 | Methyl 3-(4-methoxyphenyl)oxirane-2-carboxylate | 42245-42-1 | |
| 36 | 1-Bromo-2-methoxy-3-nitrobenzene | 67853-37-6 | |
| 37 | 2'-Methoxy-3'-nitro-biphenyl-3-carboxylic acid | 376591-94-5 | |
| 38 | 3'-Amino-2'-methoxy-biphenyl-3-carboxylic acid | 1176777-76-6 | |
| 39 | (1R,2R)-Cyclohexane-1,2-diylbis(methylene) dimethanesulfonate | 186204-35-3 | |
| 40 | (3aR,7aR)-4'-(Benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-1'-ium methanesulfonate | 186204-37-5 | |
| 41 | 4-Bromobutyl 3,4-dimethoxybenzoate | 1260668-38-9 | |
| 42 | N-Ethyl-1-(4-methoxyphenyl)propan-2-amine | 93963-24-7 | |
| 43 | 6,7-Dimethoxy-3,4-dihydroisoquinolin-2-ium chloride | 20232-39-7 | |
| 44 | 1-((6R,10S)-9,10-Dihydro-6H-6,10-methanoazepino[4,5-g]quinoxalin-8(7H)-yl)-2,2,2-trifluoroethanone | 230615-70-0 | |
| 45 | (6R,10S)-7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline | 249296-44-4 | |
| 46 | 2-(3,4-Dimethoxyphenyl)-N-methylethanamine | 3490-06-0 | |
| 47 | 3-Chloro-N-(3,4-dimethoxyphenethyl)-N-methylpropan-1-amine | 36770-74-8 | |
| 48 | 1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine hydrochloride | 960203-28-5 | |
| 49 | 1-(2-Isopropylthiazol-4-yl)-N-methylmethanamine hydrochloride | 1185167-55-8 | |
| 50 | 4-(4-Aminophenyl)morpholin-3-one | 438056-69-0 | |
| 51 | (R)-2-(Oxiran-2-ylmethyl)isoindoline-1,3-dione | 181140-34-1 | |
| 52 | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one | 898543-06-1 | |
| 53 | tert-Butyl 4-aminopiperidine-1-carboxylate | 87120-72-7 | |
| 54 | Piperidin-4-ylmethanamine | 7144-05-0 | |
| 55 | 1H-Imidazole-2-carboxylic acid | 16042-25-4 | |
| 56 | 4-Hydroxybenzaldehyde | 123-08-0 |
Standard Regulatory Documentation Package
Every shipment in our intermediates portfolio is backed by stringent QA release protocols and comprehensive regulatory dossiers.
Certificate of Analysis (COA)
Batch-specific HPLC/GC assay, impurity profiling, and physical characterization.
Material Safety Data Sheet (MSDS)
GHS-compliant safety and handling information for transport, storage, and occupational safety.
Drug Master File (DMF) Support
Open Part regulatory documentation and technical modules supporting marketing authorization.
Residual Solvents (ICH Q3C)
Gas chromatography testing confirming compliance with international residual solvent limits.
Nitrosamine & Elemental Risk Assessment
Proactive toxicology reviews and analytical screening for mutagenic impurities.
TSE / BSE & Non-GMO Declarations
Origin certifications verifying non-animal origin and compliance with international standards.
Procurement & Quality Workflow
From initial technical evaluation to commercial delivery, our process ensures total compliance and on-time supply.
Inquiry & Specification Alignment
Evaluation of target monograph, custom purity threshold, and quantity requirement.
Analytical Sampling & Validation
Dispatch of verified sample batch accompanied by full Certificate of Analysis (COA) and test methods.
Quality Controlled Production
Synthesis executed in GMP-aligned suites with continuous in-process QA/QC monitoring.
Secure Logistics & Regulatory Release
Tamper-evident packaging, temperature integrity control, and complete regulatory dossier hand-off.
Standardized Packaging
UN-approved HDPE containers, 25 kg fiber drums with double food-grade PE liners, and custom nitrogen-blanketed foil barrier packing.
Climate & Storage Integrity
Controlled room temperature (CRT) and cold-chain (+2°C to +8°C / -20°C) handling for sensitive molecules with data logger tracking.
Global Freight & Dispatch
Air and ocean freight clearance support, dangerous goods (DG) documentation, and seamless bonded warehouse transit.
Frequently Asked Questions (Intermediates)
Find answers to common questions about specifications, regulatory filings, and order fulfillment.
Enquire for Intermediates
Need a formal quotation, technical batch specifications, COA / DMF documentation, or custom molecule synthesis in this category? Fill in the details and our commercial team will respond within 24 business hours.
Pharmacopoeia Standards
Material compliance with IP, BP, USP or customized customer monographs.
Gram to Commercial Scale
From laboratory research samples to pilot batches and bulk multi-ton supply.
Fast Regulatory & Tech Support
Direct support with Certificates of Analysis, Material Safety Data Sheets, and DMF documentation.
Intermediates Enquiry Form
Fields marked with * are mandatory
Explore Other Categories
Active Pharmaceutical Ingredients
High-purity Active Pharmaceutical Ingredients manufactured under GMP-aligned quality systems and supplied with complete regulatory documentation for formulation and research applications.
Agrochemicals & Cosmetics
Speciality agrochemical intermediates and cosmetic-grade ingredients produced to consistent quality standards for crop protection, personal care and cosmetic formulation partners.
Need a specific molecule not listed in Intermediates?
Our process chemistry and contract R&D team can develop and scale custom molecules under strict CDA/NDA.